Advanced Medical Solutions Group plc (AIM:AMS)

Market Cap	460.33M +12.5%
Revenue (ttm)	228.94M +29.0%
Net Income	9.95M +40.3%
EPS	0.05 +39.1%
Shares Out	216.62M
PE Ratio	47.01
Forward PE	16.47
Dividend	0.03 (1.35%)
Ex-Dividend Date	May 28, 2026

Volume	1,035,835
Open	215.00
Previous Close	212.50
Day's Range	215.00 - 221.00
52-Week Range	187.00 - 272.00
Beta	0.72
Analysts	Strong Buy
Price Target	277.86 (+26.88%)
Earnings Date	Jun 16, 2026

About AIM:AMS

Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. The company operates in two segments, Surgical and Woundcare. It offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, infection control, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G, Vitalitec, and Acti...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1991
• Employees: 1,500
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: AMS

Financial Performance

In 2025, AIM:AMS's revenue was 228.94 million, an increase of 28.96% compared to the previous year's 177.52 million. Earnings were 9.95 million, an increase of 40.32%.